DEFINITIVE PROXY STATEMENT

Company

ARROWHEAD PHARMACEUTICALS, INC.

Filed

February 4, 2013

Period of Report

March 21, 2013

Accession Number

0001193125-13-036757

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →